Predictive value and accuracy of [F-18]FDG PET/CT modified response criteria for checkpoint immunotherapy in patients with advanced melanoma
Ayati, N; Jamshidi-Araghi, Z; Hoellwerth, M; Schweighofer-Zwink, G; Hitzl, W; Koelblinger, P; Pirich, C; Beheshti, M
EUR J NUCL MED MOL I. 2023;
Originalarbeiten (Zeitschrift)

Revisiting the Role of the CXCL13/CXCR5-Associated Immune Axis in Melanoma: Potential Implications for Anti-PD-1-Related Biomarker Research.
Hoellwerth, M; Koelblinger, P; Lang, R; Harrer, A;
Life (Basel). 2023; 13(2):
Übersichtsarbeiten

Oxidative Stress and Immune Response in Melanoma: Ion Channels as Targets of Therapy
Remigante, A; Spinelli, S; Marino, A; Pusch, M; Morabito, R; Dossena, S
INT J MOL SCI. 2023; 24(1): 887
Übersichtsarbeiten

The impact of the COVID-19 pandemic on the diagnosis of cutaneous melanomas: A retrospective cohort study from five European skin cancer reference centres.
Troesch, A; Hoellwerth, M; Forchhammer, S; Del Regno, L; Lodde, G; Turko, P; Cheng, PF; Levesque, ML; Hadaschik, E; Livingstone, E; Peris, K; Flatz, L; Peter, K; Dummer, R; Dimitriou, F;
J Eur Acad Dermatol Venereol. 2023; 37(5):922-931
Originalarbeiten (Zeitschrift)

Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG.
Franklin, C; Mohr, P; Bluhm, L; Grimmelmann, I; Gutzmer, R; Meier, F; Garzarolli, M; Weichenthal, M; Pfoehler, C; Herbst, R; Terheyden, P; Utikal, J; Ulrich, J; Debus, D; Haferkamp, S; Kaatz, M; Forschner, A; Leiter, U; Nashan, D; Kreuter, A; Sachse, M; Welzel, J; Heinzerling, L; Meiss, F; Weishaupt, C; Gambichler, T; Weyandt, G; Dippel, E; Schatton, K; Celik, E; Trommer, M; Helfrich, I; Roesch, A; Zimmer, L; Livingstone, E; Schadendorf, D; Horn, S; Ugurel, S
J IMMUNOTHER CANCER. 2022; 10(6):
Originalarbeiten (Zeitschrift)

Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis
Goldinger, SM; Buder-Bakhaya, K; Lo, SN; Forschner, A; McKean, M; Zimmer, L; Khoo, C; Dummer, R; Eroglu, Z; Buchbinder, EI; Ascierto, PA; Gutzmer, R; Rozeman, EA; Hoeller, C; Johnson, DB; Gesierich, A; Koelblinger, P; Bennannoune, N; Cohen, JV; Kahler, KC; Wilson, MA; Cebon, J; Atkinson, V; Smith, JL; Michielin, O; Long, GV; Hassel, JC; Weide, B; Haydu, LE; Schadendorf, D; McArthur, G; Ott, PA; Blank, C; Robert, C; Sullivan, R; Hauschild, A; Carlino, MS; Garbe, C; Davies, MA; Menzies, AM
EUR J CANCER. 2022; 162: 22-33.
Originalarbeiten (Zeitschrift)

MAPKinase inhibition after failure of immune checkpoint blockade in patients with advanced melanoma - An evaluation of the multicenter prospective skin cancer registry ADOREG.
Kreft, S; Glutsch, V; Zaremba, A; Schummer, P; Mohr, P; Grimmelmann, I; Gutzmer, R; Meier, F; Pföhler, C; Sachse, MM; Meiss, F; Forschner, A; Haferkamp, S; Welzel, J; Terheyden, P; Herbst, R; Utikal, J; Kaatz, M; Weishaupt, C; Kreuter, A; Debus, D; Duecker, P; Sindrilaru, A; Löffler, H; Schley, G; Weichenthal, M; Schadendorf, D; Ugurel, S; Gesierich, A; Schilling, B;
Eur J Cancer. 2022; 167: 32-41.
Originalarbeiten (Zeitschrift)

EPHA2, EPHA4, and EPHA6 Expression in Uveal Melanomas: Searching for the Culprits of Neoplasia
Pergaris, A; Danas, E; Gajdzis, P; Levidou, G; Gajdzis, M; Cassoux, N; Gardrat, S; Donizy, P; Korkolopoulou, P; Kavantzas, N; Klijanienko, J; Theocharis, S
DIAGNOSTICS. 2022; 12(5): 1025
Originalarbeiten (Zeitschrift)

The HGR motif is the antiangiogenic determinant of vasoinhibin: implications for a therapeutic orally active oligopeptide.
Robles, JP; Zamora, M; Siqueiros-Marquez, L; Adan-Castro, E; Ramirez-Hernandez, G; Nuñez, FF; Lopez-Casillas, F; Millar, RP; Bertsch, T; Martínez de la Escalera, G; Triebel, J; Clapp, C;
Angiogenesis. 2022; 25(1): 57-70.
Originalarbeiten (Zeitschrift)

Prognostic value of 2-[ 18 F]FDG PET-CT in metastatic melanoma patients receiving immunotherapy
Schweighofer-Zwink, G; Manafi-Farid, R; Kölblinger, P; Hehenwarter, L; Harsini, S; Pirich, C; Beheshti, M;
Eur J Radiol. 2022; 146: 110107
Originalarbeiten (Zeitschrift)

Ketogenic diets slow melanoma growth in vivo regardless of tumor genetics and metabolic plasticity.
Weber, DD; Aminzadeh-Gohari, S; Thapa, M; Redtenbacher, AS; Catalano, L; Capelôa, T; Vazeille, T; Emberger, M; Felder, TK; Feichtinger, RG; Koelblinger, P; Dallmann, G; Sonveaux, P; Lang, R; Kofler, B;
Cancer Metab. 2022; 10(1): 12
Originalarbeiten (Zeitschrift)

Proteome analysis of NRF2 inhibition in melanoma reveals CD44 up-regulation and increased apoptosis resistance upon vemurafenib treatment
Weitzenbock, HP; Gschwendtner, A; Wiesner, C; Depke, M; Schmidt, F; Trautinger, F; Hengstschlager, M; Hundsberger, H; Mikula, M
CANCER MED-US. 2022;
Originalarbeiten (Zeitschrift)

Choroidal melanocytes: subpopulations of different origin?
Heindl, LM; Platzl, C; Wolfmeier, H; Herwig-Carl, MC; Kaser-Eichberger, A; Strohmaier, C; Schroedl, F;
Ann Anat. 2021; 238:151775
Originalarbeiten (Zeitschrift)

COVID-19-Induced Reduction in Primary Melanoma Diagnoses: Experience from a Dermatopathology Referral Center.
Hoellwerth, M; Kaiser, A; Emberger, M; Brandlmaier, M; Laimer, M; Egger, A; Bauer, JW; Koelblinger, P;
J Clin Med. 2021; 10(18):
Originalarbeiten (Zeitschrift)

Concentration-Dependent Pro- and Antitumor Activities of Quercetin in Human Melanoma Spheroids: Comparative Analysis of 2D and 3D Cell Culture Models.
Hundsberger, H; Stierschneider, A; Sarne, V; Ripper, D; Schimon, J; Weitzenbock, HP; Schild, D; Jacobi, N; Eger, A; Atzler, J; Klein, CT; Wiesner, C
MOLECULES. 2021; 26(3):
Originalarbeiten (Zeitschrift)

Adjuvant anti-PD-1 antibody treatment in stage III/IV melanoma: real-world experience and health economic considerations.
Koelblinger, P; Hoellwerth, M; Dernoscheg, MT; Koch, L; Richtig, E; Wanner, M; Nguyen, VA; Ostermann, H; Bauer, JW; Laimer, M;
J Dtsch Dermatol Ges. 2021; 19(8): 1186-1198.
Originalarbeiten (Zeitschrift)

Histone Deacetylase (HDAC)-1, -2, -4, and -6 in Uveal Melanomas: Associations with Clinicopathological Parameters and Patients Survival.
Levidou, G; Gajdzis, P; Cassoux, N; Donizy, P; Masaoutis, C; Gajdzis, M; Gardrat, S; Pergaris, A; Danas, E; Klijanienko, J; Theocharis, S;
Cancers (Basel). 2021; 13(19):
Originalarbeiten (Zeitschrift)

Theranostics of Metastatic Prostate Cancer Applying
Mirzaei, S; Mohammed, F; Zandieh, S;
Curr Radiopharm. 2021; 14(4): 354-358.
Originalarbeiten (Zeitschrift)

Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany.
Ressler, JM; Karasek, M; Koch, L; Silmbrod, R; Mangana, J; Latifyan, S; Aedo-Lopez, V; Kehrer, H; Weihsengruber, F; Koelblinger, P; Posch, C; Kofler, J; Michielin, O; Richtig, E; Hafner, C; Hoeller, C
J IMMUNOTHER CANCER. 2021; 9(2):
Originalarbeiten (Zeitschrift)

Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG).
Steeb, T; Wessely, A; Alter, M; Bayerl, C; Bender, A; Bruning, G; Dabrowski, E; Debus, D; Devereux, N; Dippel, E; Drexler, K; Dücker, P; Dummer, R; Emmert, S; Elsner, P; Enk, A; Gebhardt, C; Gesierich, A; Goebeler, M; Goerdt, S; Goetze, S; Gutzmer, R; Haferkamp, S; Hansel, G; Hassel, JC; Heinzerling, L; Kähler, KC; Kaume, KM; Krapf, W; Kreuzberg, N; Lehmann, P; Livingstone, E; Löffler, H; Loquai, C; Mauch, C; Mangana, J; Meier, F; Meissner, M; Moritz, RKC; Maul, LV; Müller, V; Mohr, P; Navarini, A; Van Nguyen, A; Pfeiffer, C; Pföhler, C; Posch, C; Richtig, E; Rompel, R; Sachse, MM; Sauder, S; Schadendorf, D; Schatton, K; Schulze, HJ; Schultz, E; Schilling, B; Schmuth, M; Simon, JC; Streit, M; Terheyden, P; Thiem, A; Tüting, T; Welzel, J; Weyandt, G; Wesselmann, U; Wollina, U; Ziemer, M; Zimmer, L; Zutt, M; Berking, C; Schlaak, M; Heppt, MV;
J Cancer Res Clin Oncol. 2021; 147(6):1763-1771
Originalarbeiten (Zeitschrift)

Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma-A Retrospective Multicenter ADOReg Study.
Stege, H; Haist, M; Schultheis, M; Fleischer, MI; Mohr, P; Meier, F; Schadendorf, D; Ugurel, S; Livingstone, E; Zimmer, L; Herbst, R; Pfohler, C; Kahler, K; Weichenthal, M; Terheyden, P; Nashan, D; Debus, D; Kaatz, M; Ziller, F; Haferkamp, S; Forschner, A; Leiter, U; Kreuter, A; Ulrich, J; Kleemann, J; Bradfisch, F; Grabbe, S; Loquai, C
CANCERS. 2021; 13(10):
Originalarbeiten (Zeitschrift)

Preoperative Ultrasound Assessment of Regional Lymph Nodes in Melanoma Patients Does not Provide Reliable Nodal Staging: Results From a Large Multicenter Trial.
Thompson, JF; Haydu, LE; Uren, RF; Andtbacka, RH; Zager, JS; Beitsch, PD; Agnese, DM; Mozzillo, N; Testori, A; Bowles, TL; Hoekstra, HJ; Kelley, MC; Sussman, J; Schneebaum, S; Smithers, BM; McKinnon, G; Hsueh, E; Jacobs, L; Schultz, E; Reintgen, D; Kane, JM; Friedman, EB; Wang, H; Van Kreuningen, L; Schiller, V; Elashoff, DA; Elashoff, R; Cochran, AJ; Stern, S; Faries, MB;
Ann Surg. 2021; 273(4): 814-820.
Originalarbeiten (Zeitschrift)

Equivocal Longitudinal Melanonychia in a 3-Year-Old Caucasian Girl: Rapid Evolution and Fading during Digital Dermoscopy Follow-Up
Tsiogka, A; Laimer, M; Rigopoulos, D; Ahlgrimm-Siess, V
SKIN APPENDAGE DISOR. 2021;
Originalarbeiten (Zeitschrift)

Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study.
Wagner, NB; Lenders, MM; Kühl, K; Reinhardt, L; André, F; Dudda, M; Ring, N; Ebel, C; Stäger, R; Zellweger, C; Lang, R; Paar, M; Gussek, P; Richtig, G; Stürmer, SH; Kimeswenger, S; Oellinger, A; Forschner, A; Leiter, U; Weide, B; Gassenmaier, M; Schraag, A; Klumpp, B; Hoetzenecker, W; Berking, C; Richtig, E; Ziemer, M; Mangana, J; Terheyden, P; Loquai, C; Nguyen, VA; Gebhardt, C; Meier, F; Diem, S; Cozzio, A; Flatz, L; Röcken, M; Garbe, C; Eigentler, TK;
J Immunother Cancer. 2021; 9(5):
Originalarbeiten (Zeitschrift)

Targeted Metabolomics Identifies Plasma Biomarkers in Mice with Metabolically Heterogeneous Melanoma Xenografts.
Weber, DD; Thapa, M; Aminzadeh-Gohari, S; Redtenbacher, AS; Catalano, L; Feichtinger, RG; Koelblinger, P; Dallmann, G; Emberger, M; Kofler, B; Lang, R;
Cancers (Basel). 2021; 13(3):
Originalarbeiten (Zeitschrift)

Vulvar Melanoma: Molecular Characteristics, Diagnosis, Surgical Management, and Medical Treatment.
Wohlmuth, C; Wohlmuth-Wieser, I;
Am J Clin Dermatol. 2021; 22(5): 639-651.
Übersichtsarbeiten

Clinical Characteristics and Treatment Response With Checkpoint Inhibitors in Malignant Melanoma of the Vulva and Vagina.
Wohlmuth, C; Wohlmuth-Wieser, I; Laframboise, S;
J Low Genit Tract Dis. 2021; 25(2):146-151
Originalarbeiten (Zeitschrift)

Encorafenib, binimetinib plus pembrolizumab triplet therapy in patients with advanced BRAF
Zimmer, L; Livingstone, E; Krackhardt, A; Schultz, ES; Goppner, D; Assaf, C; Trebing, D; Stelter, K; Windemuth-Kieselbach, C; Ugurel, S; Schadendorf, D
Eur J Cancer. 2021; 158:72-84
Originalarbeiten (Zeitschrift)

Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients.
Amaral, T; Kiecker, F; Schaefer, S; Stege, H; Kaehler, K; Terheyden, P; Gesierich, A; Gutzmer, R; Haferkamp, S; Uttikal, J; Berking, C; Rafei-Shamsabadi, D; Reinhardt, L; Meier, F; Karoglan, A; Posch, C; Gambichler, T; Pfoehler, C; Thoms, K; Tietze, J; Debus, D; Herbst, R; Emmert, S; Loquai, C; Hassel, JC; Meiss, F; Tueting, T; Heinrich, V; Eigentler, T; Garbe, C; Zimmer, L
J IMMUNOTHER CANCER. 2020; 8(1):
Originalarbeiten (Zeitschrift)

Targeting Mitochondria in Melanoma.
Aminzadeh-Gohari, S; Weber, DD; Catalano, L; Feichtinger, RG; Kofler, B; Lang, RD
BIOMOLECULES. 2020; 10(10):
Originalarbeiten (Zeitschrift)

Midkine rewires the melanoma microenvironment toward a tolerogenic and immune-resistant state.
Cerezo-Wallis, D; Contreras-Alcalde, M; Troulé, K; Catena, X; Mucientes, C; Calvo, TG; Cañón, E; Tejedo, C; Pennacchi, PC; Hogan, S; Kölblinger, P; Tejero, H; Chen, AX; Ibarz, N; Graña-Castro, O; Martinez, L; Muñoz, J; Ortiz-Romero, P; Rodriguez-Peralto, JL; Gómez-López, G; Al-Shahrour, F; Rabadán, R; Levesque, MP; Olmeda, D; Soengas, MS;
Nat Med. 2020; 26(12): 1865-1877.
Originalarbeiten (Zeitschrift)

Epidermal activation of Hedgehog signaling establishes an immunosuppressive microenvironment in basal cell carcinoma by modulating skin immunity.
Grund-Gröschke, S; Ortner, D; Szenes-Nagy, AB; Zaborsky, N; Weiss, R; Neureiter, D; Wipplinger, M; Risch, A; Hammerl, P; Greil, R; Sibilia, M; Gratz, IK; Stoitzner, P; Aberger, F;
Mol Oncol. 2020; 14(9):1930-1946
Originalarbeiten (Zeitschrift)

Patients with BRAF-Mutant Advanced/Metastatic Melanoma: Original Research on the Treatment Reality in Germany and Austria in the Era of Choice.
Haferkamp, S; Alter, M; Debus, D; Schilling, B; Pinter, A; Terheyden, P; Utikal, JS; Sachse, MM; Haalck, T; Wolf, IH;
Adv Ther. 2020; 37(8): 361-3629.
Originalarbeiten (Zeitschrift)

The role of cyclin D1 and Ki-67 in the development and prognostication of thin melanoma.
Kaufmann, C; Kempf, W; Mangana, J; Cheng, P; Emberger, M; Lang, R; Kaiser, AK; Lattmann, E; Levesque, M; Dummer, R; Koelblinger, P
Histopathology. 2020; 77(3):460-470
Originalarbeiten (Zeitschrift)

Adjuvant and neoadjuvant treatment of melanoma
Koelblinger, P
MEMO-MAG EUR MED ONC. 2020;
Übersichtsarbeiten

Identification of microRNAs Targeting the Transporter Associated with Antigen Processing TAP1 in Melanoma.
Lazaridou, MF; Massa, C; Handke, D; Mueller, A; Friedrich, M; Subbarayan, K; Tretbar, S; Dummer, R; Koelblinger, P; Seliger, B;
J Clin Med. 2020; 9(9):
Originalarbeiten (Zeitschrift)

Survival and therapeutic response in patients with melanoma of unknown and known primary: a single-centre retrospective analysis.
Ludwig, SV; F Cheng, P; Mangana, J; Braun, R; Dummer, R; Koelblinger, P;
Eur J Dermatol. 2020; 30(6): 6-709.
Originalarbeiten (Zeitschrift)

Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score.
Schaule, J; Kroeze, SGC; Blanck, O; Stera, S; Kahl, KH; Roeder, F; Combs, SE; Kaul, D; Claes, A; Schymalla, MM; Adebahr, S; Eckert, F; Lohaus, F; Abbasi-Senger, N; Henke, G; Szuecs, M; Geier, M; Sundahl, N; Buergy, D; Dummer, R; Guckenberger, M;
Radiat Oncol. 2020; 15(1):135
Originalarbeiten (Zeitschrift)

Vascular Endothelial Growth Factor Receptor-3 Expression Predicts Sentinel Node Status in Primary Cutaneous Melanoma.
Toberer, F; Haenssle, HA; Laimer, M; Heinzel-Gutenbrunner, M; Enk, A; Hartschuh, W; Helmbold, P; Kutzner, H;
Acta Derm Venereol. 2020; 100(15):adv00235
Originalarbeiten (Zeitschrift)

Malignant Melanoma of the Vulva and Vagina: A US Population-Based Study of 1863 Patients.
Wohlmuth, C; Wohlmuth-Wieser, I; May, T; Vicus, D; Gien, LT; Laframboise, S;
Am J Clin Dermatol. 2020; 21(2):285-295
Originalarbeiten (Zeitschrift)

Diagnostic impact of reflectance confocal microscopy as a second-level examination for facial skin lesions.
Ahlgrimm-Siess, V; Weitzer, F; Arzberger, E; Laimer, M; Hofmann-Wellenhof, R;
J Dtsch Dermatol Ges. 2019; 17(3):266-273
Originalarbeiten (Zeitschrift)

Incidence, features and management of radionecrosis in melanoma patients treated with cerebral radiotherapy and anti-PD-1 antibodies.
da Silva, IP; Glitza, IC; Haydu, LE; Johnpulle, R; Banks, PD; Grass, GD; Goldinger, SMA; Smith, JL; Everett, AS; Koelblinger, P; Roberts-Thomson, R; Millward, M; Atkinson, VG; Guminski, A; Kapoor, R; Conry, RM; Carlino, MS; Wang, W; Shackleton, MJ; Eroglu, Z; Lo, S; Hong, AM; Long, GV; Johnson, DB; Menzies, AM
PIGM CELL MELANOMA R. 2019; 32(4): 553-563.
Originalarbeiten (Zeitschrift)

Characterizing CD44 regulatory microRNAs as putative therapeutic agents in human melanoma.
Fänder, J; Kielstein, H; Büttner, M; Koelblinger, P; Dummer, R; Bauer, M; Handke, D; Wickenhauser, C; Seliger, B; Jasinski-Bergner, S;
Oncotarget. 2019; 10(60): 6509-6525.
Originalarbeiten (Zeitschrift)

The spectrum of cutaneous adverse events during encorafenib and binimetinib treatment in B-rapidly accelerated fibrosarcoma-mutated advanced melanoma.
Graf, NP; Koelblinger, P; Galliker, N; Conrad, S; Barysch, M; Mangana, J; Dummer, R; Cheng, PF; Goldinger, SM;
J Eur Acad Dermatol Venereol. 2019; 33(4): 686-692.
Originalarbeiten (Zeitschrift)

Increased tumour cell PD-L1 expression, macrophage and dendritic cell infiltration characterise the tumour microenvironment of ulcerated primary melanomas.
Koelblinger, P; Emberger, M; Drach, M; Cheng, PF; Lang, R; Levesque, MP; Bauer, JW; Dummer, R;
J Eur Acad Dermatol Venereol. 2019; 33(4):667-675
Originalarbeiten (Zeitschrift)

Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases.
Rauschenberg, R; Bruns, J; Brutting, J; Daubner, D; Lohaus, F; Zimmer, L; Forschner, A; Zips, D; Hassel, JC; Berking, C; Kaehler, KC; Utikal, J; Gutzmer, R; Terheyden, P; Meiss, F; Rafei-Shamsabadi, D; Kiecker, F; Debus, D; Dabrowski, E; Arnold, A; Garzarolli, M; Kuske, M; Beissert, S; Lock, S; Linn, J; Troost, EGC; Meier, F
EUR J CANCER. 2019; 110: 11-20.
Originalarbeiten (Zeitschrift)

Vulvar malignancies: an interdisciplinary perspective.
Wohlmuth, C; Wohlmuth-Wieser, I;
J Dtsch Dermatol Ges. 2019; 17(12): 1257-1276.
Originalarbeiten (Zeitschrift)

Confocal Microscopy in Skin Cancer.
Ahlgrimm-Siess, V; Laimer, M; Rabinovitz, HS; Oliviero, M; Hofmann-Wellenhof, R; Marghoob, AA; Scope, A;
Curr Dermatol Rep. 2018; 7(2): 105-118.
Übersichtsarbeiten

Androgen receptor functions as transcriptional repressor of cancer-associated fibroblast activation.
Clocchiatti, A; Ghosh, S; Procopio, MG; Mazzeo, L; Bordignon, P; Ostano, P; Goruppi, S; Bottoni, G; Katarkar, A; Levesque, M; Kolblinger, P; Dummer, R; Neel, V; Ozdemir, BC; Dotto, GP
J CLIN INVEST. 2018; 128(12): 5531-5548.
Originalarbeiten (Zeitschrift)

TR47, a PAR1-based peptide, inhibits melanoma cell migration in vitro and metastasis in vivo.
de Oliveira, AS; de Almeida, VH; Gomes, FG; Rezaie, AR; Monteiro, RQ;
Biochem Biophys Res Commun. 2018; 495(1):-1304.
Originalarbeiten (Zeitschrift)

Melanoma tumors exhibit a variable but distinct metabolic signature.
Feichtinger, RG; Lang, R; Geilberger, R; Rathje, F; Mayr, JA; Sperl, W; Bauer, JW; Hauser-Kronberger, C; Kofler, B; Emberger, M;
Exp Dermatol. 2018; 27(2):204-207
Letter

Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancer.
Hochmann, S; Mittermeir, M; Santic, R; Koszik, F; Griessner, L; Sonderegger, AS; Hoffmann, T; Russe, E; Scheiblhofer, S; Weiss, R; Mandler, M; Schneeberger, A; Strunk, D;
Sci Rep. 2018; 8(1): 12954
Originalarbeiten (Zeitschrift)

Development of encorafenib for BRAF-mutated advanced melanoma.
Koelblinger, P; Thuerigen, O; Dummer, R;
Curr Opin Oncol. 2018; 30(2): 125-133.
Originalarbeiten (Zeitschrift)

Inosine Released from Dying or Dead Cells Stimulates Cell Proliferation
Chen, J; Chaurio, RA; Maueröder, C; Derer, A; Rauh, M; Kost, A; Liu, Y; Mo, X; Hueber, A; Bilyy, R; Herrmann, M; Zhao, Y; Muñoz, LE;
Front Immunol. 2017; 8:504
Originalarbeiten (Zeitschrift)

MEK inhibition and immune responses in advanced melanoma
Dummer, R; Ramelyte, E; Schindler, S; Thurigen, O; Levesque, MP; Koelblinger, P
ONCOIMMUNOLOGY. 2017; 6(8): e1335843
Übersichtsarbeiten

Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.
Faries, MB; Thompson, JF; Cochran, AJ; Andtbacka, RH; Mozzillo, N; Zager, JS; Jahkola, T; Bowles, TL; Testori, A; Beitsch, PD; Hoekstra, HJ; Moncrieff, M; Ingvar, C; Wouters, MWJM; Sabel, MS; Levine, EA; Agnese, D; Henderson, M; Dummer, R; Rossi, CR; Neves, RI; Trocha, SD; Wright, F; Byrd, DR; Matter, M; Hsueh, E; MacKenzie-Ross, A; Johnson, DB; Terheyden, P; Berger, AC; Huston, TL; Wayne, JD; Smithers, BM; Neuman, HB; Schneebaum, S; Gershenwald, JE; Ariyan, CE; Desai, DC; Jacobs, L; McMasters, KM; Gesierich, A; Hersey, P; Bines, SD; Kane, JM; Barth, RJ; McKinnon, G; Farma, JM; Schultz, E; Vidal-Sicart, S; Hoefer, RA; Lewis, JM; Scheri, R; Kelley, MC; Nieweg, OE; Noyes, RD; Hoon, DSB; Wang, HJ; Elashoff, DA; Elashoff, RM;
N Engl J Med. 2017; 376(23): 2211-2222.
Originalarbeiten (Zeitschrift)

Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients.
Gross, S; Erdmann, M; Haendle, I; Voland, S; Berger, T; Schultz, E; Strasser, E; Dankerl, P; Janka, R; Schliep, S; Heinzerling, L; Sotlar, K; Coulie, P; Schuler, G; Schuler-Thurner, B;
JCI Insight. 2017; 2(8):
Originalarbeiten (Zeitschrift)

A review of binimetinib for the treatment of mutant cutaneous melanoma
Koelblinger, P; Dornbierer, J; Dummer, R
FUTURE ONCOL. 2017; 13(20): 1-12.
Übersichtsarbeiten

Targeted treatment of advanced NRAS-mutated melanoma.
Koelblinger, P; Dummer, R;
Oncotarget. 2017; 8(49):-84617
Editorials

Noninvasive RCM for Differentiation of Melanotic Macules From Melanocytic Lesions-Blinded Evaluation of a Series of 42 Pigmented Macules.
Laimer, M; Arzberger, E; Kirchner, CA; Prodinger, C; Hofmann-Wellenhof, R; Ahlgrimm-Siess, V;
Dermatol Surg. 2017; 43(7): 911-919.
Originalarbeiten (Zeitschrift)

How to prevent a pacemaker implantation after sutureless bioprosthesis.
Fischlein, T; Gersak, B; Pfeiffer, S
J THORAC CARDIOV SUR. 2016; 152(2): 635-636.
Letter

Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma: results of a phase I dose escalation study.
Gutzmer, R; Rivoltini, L; Levchenko, E; Testori, A; Utikal, J; Ascierto, PA; Demidov, L; Grob, JJ; Ridolfi, R; Schadendorf, D; Queirolo, P; Santoro, A; Loquai, C; Dreno, B; Hauschild, A; Schultz, E; Lesimple, TP; Vanhoutte, N; Salaun, B; Gillet, M; Jarnjak, S; De Sousa Alves, PM; Louahed, J; Brichard, VG; Lehmann, FF;
ESMO Open. 2016; 1(4): e000068
Originalarbeiten (Zeitschrift)

Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy
Heinzerling, L; Ott, PA; Hodi, FS; Husain, AN; Tajmir-Riahi, A; Tawbi, H; Pauschinger, M; Gajewski, TF; Lipson, EJ; Luke, JJ
J IMMUNOTHER CANCER. 2016; 4: 50
Originalarbeiten (Zeitschrift)

Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysis.
Heppt, MV; Eigentler, TK; Kahler, KC; Herbst, RA; Goppner, D; Gambichler, T; Ulrich, J; Dippel, E; Loquai, C; Schell, B; Schilling, B; Schad, SG; Schultz, ES; Matheis, F; Tietze, JK; Berking, C
Cancer Immunol Immunother. 2016; 65(8):951-959
Originalarbeiten (Zeitschrift)

KPS/LDH index: a simple tool for identifying patients with metastatic melanoma who are unlikely to benefit from palliative whole brain radiotherapy.
Partl, R; Fastner, G; Kaiser, J; Kronhuber, E; Cetin-Strohmer, K; Steffal, C; Böhmer-Breitfelder, B; Mayer, J; Avian, A; Berghold, A;
Support Care Cancer. 2016; 24(2): 523-528.
Originalarbeiten (Zeitschrift)

Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 cases.
Berghoff, AS; Ilhan-Mutlu, A; Dinhof, C; Magerle, M; Hackl, M; Widhalm, G; Hainfellner, JA; Dieckmann, K; Pichler, J; Hutterer, M; Melchardt, T; Bartsch, R; Zielinski, CC; Birner, P; Preusser, M;
Neuropathol Appl Neurobiol. 2015; 41(2):e41-e55
Originalarbeiten (Zeitschrift)

Filamin A interacts with the coactivator MKL1 to promote the activity of the transcription factor SRF and cell migration.
Kircher, P; Hermanns, C; Nossek, M; Drexler, MK; Grosse, R; Fischer, M; Sarikas, A; Penkava, J; Lewis, T; Prywes, R; Gudermann, T; Muehlich, S;
Sci Signal. 2015; 8(402):ra112
Originalarbeiten (Zeitschrift)

Genetic Characterization of Ten-Eleven-Translocation Methylcytosine Dioxygenase Alterations in Human Glioma.
Kraus, TF; Greiner, A; Steinmaurer, M; Dietinger, V; Guibourt, V; Kretzschmar, HA;
J Cancer. 2015; 6(9):83-42
Originalarbeiten (Zeitschrift)

Intermittent High-Dose Intravenous Interferon Alfa-2b for Adjuvant Treatment of Stage III Melanoma: Final Analysis of a Randomized Phase III Dermatologic Cooperative Oncology Group Trial.
Mohr, P; Hauschild, A; Trefzer, U; Enk, A; Tilgen, W; Loquai, C; Gogas, H; Haalck, T; Koller, J; Dummer, R; Gutzmer, R; Brockmeyer, N; Holzle, E; Sunderkotter, C; Mauch, C; Stein, A; Schneider, LA; Podda, M; Goppner, D; Schadendorf, D; Weichenthal, M
J Clin Oncol. 2015; 33(34):4077-4084
Originalarbeiten (Zeitschrift)

Value of anatomic site, histology and clinicopathological parameters for prediction of lymph node metastasis and overall survival in head and neck melanomas.
Ettl, T; Irga, S; Müller, S; Rohrmeier, C; Reichert, TE; Schreml, S; Gosau, M;
J Craniomaxillofac Surg. 2014; 42(5): e252-e258.
Originalarbeiten (Zeitschrift)

UV-induced alterations of the skin evaluated over time by reflectance confocal microscopy.
Koller, S; Inzinger, M; Rothmund, M; Ahlgrimm-Siess, V; Massone, C; Arzberger, E; Wolf, P; Hofmann-Wellenhof, R
J Eur Acad Dermatol Venereol. 2014; 28(8):1061-1068
Originalarbeiten (Zeitschrift)

The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells.
Paolino, M; Choidas, A; Wallner, S; Pranjic, B; Uribesalgo, I; Loeser, S; Jamieson, AM; Langdon, WY; Ikeda, F; Fededa, JP; Cronin, SJ; Nitsch, R; Schultz-Fademrecht, C; Eickhoff, J; Menninger, S; Unger, A; Torka, R; Gruber, T; Hinterleitner, R; Baier, G; Wolf, D; Ullrich, A; Klebl, BM; Penninger, JM
Nature. 2014; 507(7493):508-512
Originalarbeiten (Zeitschrift)

Role of Rho/ROCK signaling in the interaction of melanoma cells with the blood-brain barrier
Wilhelm, I; Fazakas, C; Molnar, J; Hasko, J; Vegh, AG; Cervenak, L; Nagyoszi, P; Nyul-Toth, A; Farkas, AE; Bauer, H; Guillemin, GJ; Bauer, HC; Varo, G; Krizbai, IA
PIGM CELL MELANOMA R. 2014; 27(1): 11-23.
Originalarbeiten (Zeitschrift)

Influence of time on dermoscopic diagnosis and management.
Jaimes, N; Dusza, SW; Quigley, EA; Braun, RP; Puig, S; Malvehy, J; Kittler, H; Rabinovitz, HS; Oliviero, MC; Soyer, HP; Grichnik, JM; Korzenko, A; Cabo, H; Carlos-Ortega, B; Ahlgrimm-Siess, V; Kopf, AW; Marghoob, AA;
Australas J Dermatol. 2013; 54(2):96-104
Originalarbeiten (Zeitschrift)

New diagnostics for melanoma detection: from artificial intelligence to RNA microarrays.
Ahlgrimm-Siess, V; Laimer, M; Arzberger, E; Hofmann-Wellenhof, R;
FUTURE ONCOL. 2012; 8(7): 819-827.
Übersichtsarbeiten

[Pigmented lesions of the oral mucosa].
Beck-Mannagetta, J; Hutarew, G;
Hautarzt. 2012; 63(9):704-709
Originalarbeiten (Zeitschrift)

Agreement of dermatopathologists in the evaluation of clinically difficult melanocytic lesions: how golden is the "gold standard"?
Braun, RP; Gutkowicz-Krusin, D; Rabinovitz, H; Cognetta, A; Hofmann-Wellenhof, R; Ahlgrimm-Siess, V; Polsky, D; Oliviero, M; Kolm, I; Googe, P; King, R; Prieto, VG; French, L; Marghoob, A; Mihm, M;
Dermatology. 2012; 224(1):51-58
Originalarbeiten (Zeitschrift)

Dermoscopy for the pediatric dermatologist, part ii: dermoscopy of genetic syndromes with cutaneous manifestations and pediatric vascular lesions.
Haliasos, EC; Kerner, M; Jaimes, N; Zalaudek, I; Malvehy, J; Lanschuetzer, CM; Hinter, H; Hofmann-Wellenhof, R; Braun, RP; Marghoob, AA;
Pediatr Dermatol. 2012; 30(2):172-181
Übersichtsarbeiten

[Safety of immunosuppressants].
Psenak, O; Studnicka-Benke, A; Greil, R;
Z Rheumatol. 2012; 71(5):420-429
Originalarbeiten (Zeitschrift)

Sinonasal, genital and acrolentiginous melanomas show distinct characteristics of KIT expression and mutations.
Schoenewolf, NL; Bull, C; Belloni, B; Holzmann, D; Tonolla, S; Lang, R; Mihic-Probst, D; Andres, C; Dummer, R;
Eur J Cancer. 2012; 48(12):184-152
Originalarbeiten (Zeitschrift)

Vascular targeting tumor therapy: non-invasive contrast enhanced ultrasound for quantitative assessment of tumor microcirculation.
Eichhorn, ME; Klotz, LV; Luedemann, S; Strieth, S; Kleespies, A; Preissler, G; Lindner, M; Jauch, KW; Reiser, MF; Clevert, DA;
Cancer Biol Ther. 2010; 9(10):794-802
Originalarbeiten (Zeitschrift)

Pigment nevi in children
Koller, J
HAUTARZT. 2010; 61(5): 443-451.
Originalarbeiten (Zeitschrift)

Reflectance confocal microscopy in the daily practice.
Ahlgrimm-Siess, V; Hofmann-Wellenhof, R; Cao, T; Oliviero, M; Scope, A; Rabinovitz, HS;
SEMIN CUTAN MED SURG. 2009; 28(3): 180-189.
Originalarbeiten (Zeitschrift)

Reflectance confocal microscopy of facial lentigo maligna and lentigo maligna melanoma: a preliminary study.
Ahlgrimm-Siess, V; Massone, C; Scope, A; Fink-Puches, R; Richtig, E; Wolf, IH; Koller, S; Gerger, A; Smolle, J; Hofmann-Wellenhof, R;
BRIT J DERMATOL. 2009; 161(6): 1307-1316.
Originalarbeiten (Zeitschrift)

Melanoma-associated chondroitin sulphate proteoglycan as a new target antigen for CD4+ T cells in melanoma patients.
Erfurt, C; Müller, E; Emmerling, S; Klotz, C; Hertl, M; Schuler, G; Schultz, ES;
Int J Cancer. 2009; 124(10): 2341-2346.
Originalarbeiten (Zeitschrift)

Advanced metastatic melanoma during pregnancy: a multidisciplinary challenge.
Gottschalk, N; Jacobs, VR; Hein, R; Fischer, T; Schneider, KT; Pildner von Steinburg, S;
Onkologie. 2009; 32(12): 748-751.
Originalarbeiten (Zeitschrift)

Intraocular lymphangiogenesis in malignant melanomas of the ciliary body with extraocular extension.
Heindl, LM; Hofmann, TN; Knorr, HL; Rummelt, C; Schrödl, F; Schlötzer-Schrehardt, U; Holbach, LM; Naumann, GO; Kruse, FE; Cursiefen, C;
Invest Ophthalmol Vis Sci. 2009; 50(5): 1988-1995.
Originalarbeiten (Zeitschrift)

In vivo confocal scanning laser microscopy of common naevi with globular, homogeneous and reticular pattern in dermoscopy.
Ahlgrimm-Siess, V; Massone, C; Koller, S; Fink-Puches, R; Richtig, E; Wolf, I; Gerger, A; Hofmann-Wellenhof, R;
Br J Dermatol. 2008; 158(5):1000-1007
Originalarbeiten (Zeitschrift)

In vivo confocal laser scanning microscopy of melanocytic skin tumours: diagnostic applicability using unselected tumour images.
Gerger, A; Hofmann-Wellenhof, R; Langsenlehner, U; Richtig, E; Koller, S; Weger, W; Ahlgrimm-Siess, V; Horn, M; Samonigg, H; Smolle, J;
Br J Dermatol. 2008; 158(2):329-333
Originalarbeiten (Zeitschrift)

Leptomeningeal melanoma of unknown primary site: two cases with an atypical presentation of acute meningitis.
Levidou, G; Korkolopoulou, P; Papetta, A; Patsouris, E; Agapitos, E;
Clin Neuropathol. 2008; 26(6):299-305
Übersichtsarbeiten

Dermoscopic evaluation of amelanotic and hypomelanotic melanoma.
Menzies, SW; Kreusch, J; Byth, K; Pizzichetta, MA; Marghoob, A; Braun, R; Malvehy, J; Puig, S; Argenziano, G; Zalaudek, I; Rabinovitz, HS; Oliviero, M; Cabo, H; Ahlgrimm-Siess, V; Avramidis, M; Guitera, P; Soyer, HP; Ghigliotti, G; Tanaka, M; Perusquia, AM; Pagnanelli, G; Bono, R; Thomas, L; Pellacani, G; Langford, D; Piccolo, D; Terstappen, K; Stanganelli, I; Llambrich, A; Johr, R;
Arch Dermatol. 2008; 144(9):1120-1127
Kommentare

[Immunization strategies for treating melanoma].
Schultz, ES; Schuler, G;
Hautarzt. 2008; 59(10):785-792
Übersichtsarbeiten

Ferritin--a mediator of apoptosis?
Bresgen, N; Ohlenschläger, I; Fiedler, B; Wacht, N; Zach, S; Dunkelmann, B; Arosio, P; Kuffner, E; Lottspeich, F; Eckl, PM;
J Cell Physiol. 2007; 212(1): 157-164.
Originalarbeiten (Zeitschrift)

Pretreatment levels of sTNF-R1 and sIL-6R are associated with a higher vulnerability for IFN-alpha-induced depressive symptoms in patients with malignant melanoma.
Friebe, A; Schwarz, MJ; Schmid-Wendtner, M; Volkenandt, M; Schmidt, F; Horn, M; Janssen, G; Schaefer, M;
J Immunother. 2007; 30(3):333-337
Originalarbeiten (Zeitschrift)

Chemoimmunotherapy with dacarbazine, cisplatin, interferon-alpha2b and interleukin-2 versus two cycles of dacarbazine followed by chemoimmunotherapy in patients with metastatic melanoma: a randomised phase II study of the European Organization for Research and Treatment of Cancer Melanoma Group.
Punt, CJ; Suciu, S; Gore, MA; Koller, J; Kruit, WH; Thomas, J; Patel, P; Lienard, D; Eggermont, AM; Keilholz, U;
Eur J Cancer. 2006; 42(17):2991-2995
Originalarbeiten (Zeitschrift)

Artesunate in the treatment of metastatic uveal melanoma--first experiences.
Berger, TG; Dieckmann, D; Efferth, T; Schultz, ES; Funk, JO; Baur, A; Schuler, G;
Oncol Rep. 2005; 14(6): 1599-1603.
Originalarbeiten (Zeitschrift)

Epidermolysis bullosa naevi reveal a distinctive dermoscopic pattern.
Lanschuetzer, CM; Emberger, M; Laimer, M; Diem, A; Bauer, JW; Soyer, HP; Hintner, H;
BRIT J DERMATOL. 2005; 153(1): 97-102.
Originalarbeiten (Zeitschrift)

Differences in phenotype and function between spontaneously occurring melan-A-, tyrosinase- and influenza matrix peptide-specific CTL in HLA-A*0201 melanoma patients.
Maczek, C; Berger, TG; Schuler-Thurner, B; Schultz, ES; Hamann, A; Dunbar, PR; Cerundolo, V; Steinkasserer, A; Schuler, G;
Int J Cancer. 2005; 115(3):450-455
Originalarbeiten (Zeitschrift)

[Malignant melanoma. Diagnosis and therapy].
Schultz, ES; Schuler, G;
HNO. 2005; 53(11):928-939
Übersichtsarbeiten

The role of calponin in the gene profile of metastatic cells: inhibition of metastatic cell motility by multiple calponin repeats.
Lener, T; Burgstaller, G; Gimona, M;
FEBS Lett. 2004; 556(1-3):221-226
Originalarbeiten (Zeitschrift)

Optimization of codon usage is required for effective genetic immunization against Art v 1, the major allergen of mugwort pollen.
Bauer, R; Himly, M; Dedic, A; Ferreira, F; Thalhamer, J; Hartl, A;
Allergy. 2003; 58(10):1003-1010
Originalarbeiten (Zeitschrift)

Photoperiod modulates melanoma growth in C57BL/6 mice.
Lang, R; Hintner, H; Hermann, A; Brandstaetter, R;
EXP DERMATOL. 2003; 12(4): 510-513.
Originalarbeiten (Zeitschrift)

Antigen loading of dendritic cells with whole tumor cell preparations.
Thumann, P; Moc, I; Humrich, J; Berger, TG; Schultz, ES; Schuler, G; Jenne, L;
J Immunol Methods. 2003; 277(1-2):-16
Originalarbeiten (Zeitschrift)

Metallothionein-overexpression as a prognostic factor for progression and survival in melanoma. A prospective study on 520 patients.
Weinlich, G; Bitterlich, W; Mayr, V; Fritsch, PO; Zelger, B;
BRIT J DERMATOL. 2003; 149(3): 535-541.
Originalarbeiten (Zeitschrift)

Noscapine alters microtubule dynamics in living cells and inhibits the progression of melanoma.
Landen, JW; Lang, R; McMahon, SJ; Rusan, NM; Yvon, AM; Adams, AW; Sorcinelli, MD; Campbell, R; Bonaccorsi, P; Ansel, JC; Archer, DR; Wadsworth, P; Armstrong, CA; Joshi, HC;
Cancer Res. 2002; 62(14): 4109-4114.
Originalarbeiten (Zeitschrift)

Testing a new staging system for cutaneous melanoma proposed by the American Joint Committee on Cancer.
Merkel, S; Meyer, T; Papadopoulos, T; Schuler, G; Gohl, J; Hohenberger, W; Hermanek, P
EUR J CANCER. 2002; 38(4): 517-526.
Originalarbeiten (Zeitschrift)

Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells.
Schuler-Thurner, B; Schultz, ES; Berger, TG; Weinlich, G; Ebner, S; Woerl, P; Bender, A; Feuerstein, B; Fritsch, PO; Romani, N; Schuler, G;
J Exp Med. 2002; 195(10): 1279-1288.
Originalarbeiten (Zeitschrift)

Biphasic response to human galanin of extracellular acidification in human Bowes melanoma cells.
Lang, R; Berger, A; Hermann, A; Kofler, B;
Eur J Pharmacol. 2001; 423(2-3): 135-141.
Originalarbeiten (Zeitschrift)

[The validity of the Hornheide questionnaire for psychosocial support in skin tumor patients: a survey in an Austrian and German outpatient population with melanoma].
Rumpold, G; Augustin, M; Zschocke, I; Strittmatter, G; Söllner, W;
Psychother Psychosom Med Psychol. 2001; 51(1):25-33
Originalarbeiten (Zeitschrift)

A localized variant of paraneoplastic pemphigus: acantholysis associated with malignant melanoma.
Schaeppi, H; Bauer, JW; Hametner, R; Metze, D; Ortiz-Urda, S; Salmhofer, W; Rappersberger, K; Hintner, H;
Br J Dermatol. 2001; 144(6): 1249-1254.
Fallberichte

A MAGE-A3 peptide presented by HLA-DP4 is recognized on tumor cells by CD4+ cytolytic T lymphocytes.
Schultz, ES; Lethé, B; Cambiaso, CL; Van Snick, J; Chaux, P; Corthals, J; Heirman, C; Thielemans, K; Boon, T; van der Bruggen, P;
Cancer Res. 2000; 60(22):6272-6275
Originalarbeiten (Zeitschrift)

Betulinic acid: a new cytotoxic agent against malignant brain-tumor cells.
Fulda, S; Jeremias, I; Steiner, HH; Pietsch, T; Debatin, KM;
Int J Cancer. 1999; 82(3):435-441
Originalarbeiten (Zeitschrift)

Expression and functional significance of vascular endothelial growth factor receptors in human tumor cells.
Herold-Mende, C; Steiner, HH; Andl, T; Riede, D; Buttler, A; Reisser, C; Fusenig, NE; Mueller, MM;
Lab Invest. 1999; 79(12):1573-1582
Originalarbeiten (Zeitschrift)

Interactive patterns of social support and individual coping strategies in melanoma patients and their correlations with adjustment to illness.
Söllner, W; Zschocke, I; Zingg-Schir, M; Stein, B; Rumpold, G; Fritsch, P; Augustin, M;
Psychosomatics. 1999; 40(3):239-250
Originalarbeiten (Zeitschrift)

Clinical and prognostic relevance of serum S-100 beta protein in malignant melanoma.
Schultz, ES; Diepgen, TL; Von Den Driesch, P;
Br J Dermatol. 1998; 138(3):426-430
Originalarbeiten (Zeitschrift)

Need for supportive counselling--the professionals" versus the patients" perspective. A survey in a representative sample of 236 melanoma patients.
Söllner, W; Zingg-Schir, M; Rumpold, G; Mairinger, G; Fritsch, P;
Psychother Psychosom. 1998; 67(2):94-104
Originalarbeiten (Zeitschrift)

[Melanoma patients: psychosocial stress, coping with illness and social support. A systematic review].
Söllner, W; Zschocke, I; Augustin, M;
Psychother Psychosom Med Psychol. 1998; 48(9-10):338-348
Übersichtsarbeiten

Attitude toward alternative therapy, compliance with standard treatment, and need for emotional support in patients with melanoma.
Söllner, W; Zingg-Schir, M; Rumpold, G; Fritsch, P;
Arch Dermatol. 1997; 133(3):316-321
Originalarbeiten (Zeitschrift)

[Cancer prognosis, psychosocial stress and attitude of melanoma patients to supportive psychotherapy].
Söllner, W; Mairinger, G; Zingg-Schir, M; Fritsch, P;
Hautarzt. 1996; 47(3):200-205
Originalarbeiten (Zeitschrift)

Human melanocytes and melanoma cells constitutively express the Bcl-2 proto-oncogene in situ and in cell culture.
PLETTENBERG, A; BALLAUN, C; PAMMER, J; MILDNER, M; STRUNK, D; WENINGER, W; TSCHACHLER, E
Am J Pathol. 1995; 146(3):651-659
Originalarbeiten (Zeitschrift)

Influence of various cytokines on the interleukin-2-dependent lysis of melanoma cells in vitro.
Schultz, ES; Dummer, R; Becker, JC; Zillikens, D; Burg, G;
Arch Dermatol Res. 1994; 286(2):73-76
Originalarbeiten (Zeitschrift)

[Melanoma of the iris with recurrent hyphema--course over 32 years].
Schmidbauer, JM; Burk, RO; Daus, W; Völcker, HE;
Klin Monbl Augenheilkd. 1993; 203(2): 117-120.
Fallberichte

[Cytologic molecular detection of oncogene expression: possibilities and prospects in hemato-oncology].
Greil, R; Fasching, B; Huber, H;
Acta Med Austriaca. 1990; 17(1): 6-10.
Übersichtsarbeiten

Importance of an 85 kDa membrane glycoprotein for a variety of cell-cell interactions.
Schulz, TF; Vogetseder, W; Mitterer, M; Neumayer, HP; Myones, BL; Stauder, R; Greil, R; Böck, G; Feichtinger, H; Huber, H;
Mol Immunol. 1988; 25(11):1053-1061
Originalarbeiten (Zeitschrift)